[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)]. Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 Pt 2):78-81. PMID: 24416812. Abstract CommentRecommendBookmarkWatch